WuXi Biologics CRDMO Qatar MOU Establishes First Middle East Center
WuXi Biologics (HKG: 2269) announced it has signed a strategic Memorandum of Understanding (MOU) with...
CRO / CMO / CDMO
ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development
Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG:...
Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research
Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China,...
Pharmaron Expands CRO Footprint with 82.5% Acquisition of Biortus in $200 M Deal
China‑based Pharmaron Beijing Co., Ltd. (HKG: 3759) announced on October 28, 2025 that it will acquire an...
WuXi AppTec Signs Dual MoUs with NEOM and Saudi Ministry of Health to Advance Localized Drug Development
WuXi AppTec Co., Ltd. (SHA: 603259, HKG: 2359) today announced the signing of strategic Memoranda of...
Wuxi Apptec Reports 15.3 % YoY Revenue Growth in Q3 2025, Net Profit Hits RMB 4.22 Billion
Wuxi Apptec Co., Ltd. (SHA: 603259, HKG: 2359) today announced third‑quarter 2025 financial results, delivering...
Tigermed Completes Share Transfer of Teddy Clinical Laboratory to Frontage Laboratories for RMB 270 Million
China‑based Hangzhou Tigermed Consulting Co., Ltd. (HKG: 3347) announced that it and its subsidiary Jiaxing...
Shanghai MicuRx and GenScript’s ProBio Unit Sign Strategic Deal to Accelerate Antibody‑Drug Conjugate (ADC) Development
Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA: 688373) and Nanjing ProBio, a subsidiary of GenScript Biotech...
China’s Insilico, Mabwell, and Chemexpress Forge AI‑Driven ADC Collaboration
Insilico Medicine, a global leader in generative AI‑driven drug discovery, announced a strategic partnership with...
Biocytogen Eyes A‑Share Listing on Shanghai’s STAR Market to Fund Preclinical R&D Growth
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has filed a prospectus announcing plans to seek...
ChemPartner & Hayoo Forge Nucleic‑Acid Delivery Partnership to Expand Extranodal Therapies
Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149) and Hayoo Biotech have...
PackGene & CMRI Announce AAV Screening Kit for Global Gene Therapy R&D
PackGene LLC, a global leader in gene‑therapy contract development and manufacturing, and the Children’s Medical...
WuXi Biologics Reports 16.1% Revenue Growth in H1 2025, Launches WuXiHigh 2.0 Platform
WuXi Biologics (Cayman) Inc. (HKG: 2269), a leading global Contract Research, Development and Manufacturing Organization...
CANbridge Pharmaceuticals Secures HK 100 Million Equity Financing From Baheal Pharma
CANbridge Pharmaceuticals (HKG: 1228) announced on August 13, 2025, that it has entered into a...
Tigermed Partners with Africare BioPharma to Enhance Africa’s Clinical Research Capabilities
On August 8, 2025, Hangzhou Tigermed Consulting (SHE: 300347, HKG: 3347), a China-based contract research...
ChemPartner and Leado Pharma Sign Strategic Agreement to Advance New Drug R&D
Shanghai ChemPartner Co., Ltd. (“ChemPartner”) and Shanghai Leado Pharma Co., Ltd. (“Leado Pharma”) have officially...
WuXi Biologics Passes FDA Pre-Approval Inspection with Zero Critical Findings
WuXi Biologics (HKG: 2269) announced on July 21, 2025, that five of its manufacturing facilities...
3SBio Partners with Thermo Fisher to Advance Cell and Gene Therapy Solutions
China-based 3SBio Inc. (HKG: 1530) announced last week a strategic partnership with US-based life sciences...
Suzhou Porton Biologics Partners with Future Biotechnology to Expand Viral Vector Services
China-based Contract Development and Manufacturing Organization (CDMO) Suzhou Porton Biologics Ltd announced this week a...
WuXi Biologics Commences Construction on Microbial Production Base in Chengdu
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) announced the official...